Lifelogger Technologies Corp

CIK:0001567771|SEC Filings

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Operating expenses:
Professional fees	$ 10,670	$ 32,210
General and administrative	160,099	176,422
Amortization expense	41,723	1,958
Total operating expenses	212,492	210,590
Loss from operations	(212,492)	(210,590)
Other income (expenses)
Change in fair value of derivative liabilities	129,065	37,994
Loss on derivative liabilities		(1,739,698)
Interest expense	(171,256)	(99,330)
Total other income (expenses)	(42,191)	(1,801,034)
Loss from continuing operations before income tax provision	(254,683)	(2,011,624)
Income tax provision
Loss before income tax provision	(254,683)	(2,011,624)
Net loss	(254,683)	(2,011,624)
Series B preferred stock dividend	(9,986)	(9,986)
Net loss attributable to common stockholders	$ (264,669)	$ (2,021,610)
Net loss per Common share:
- Basic and Diluted	$ (0.11)	$ (0.84)
Weighted average commons shares Outstanding:
- Basic and Diluted	2,410,229	2,410,229

Consolidated Statements of CashFlows (Unaudited) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Cash flows from Operating Activities:
Net loss	$ (254,683)	$ (2,011,624)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expenses	2,337	1,958
Interest expense on convertible notes
Initial recognition of loss of derivative liabilities		1,739,698
Interest expense accretion of convertible notes discount	91,222	99,330
Change in fair value of derivative liabilities	(129,065)	(37,994)
Non cash operating lease expense	39,386	39,387
Changes in Operating Assets and Liabilities:
Prepaid expense		(17,244)
Security Deposits		(66,155)
Due from related parties	11,374	(70,697)
Accounts payable and accrued expenses	185,443	(21,151)
Right of use liabilities	(29,998)	(25,482)
Net cash used in operating activities	(106,732)	(369,974)
Cash flows from Investing Activities:
Purchases of property and equipment		(66,378)
Net cash used in investing activities		(66,378)
Cash flows from Financing Activities:
Proceeds from notes payable	150,000
Proceeds from convertible notes	45,000	750,000
Net cash provided by financing activities	195,000	750,000
Net Change in Cash	88,268	313,648
Cash - Beginning of Reporting Period	1,915
Cash - End of Reporting Period	90,183	313,648	$ 1,915
Supplemental Disclosure of Cash Flow Information
Interest Paid
Income tax paid
Issuance of Series B preferred stock as compensation for deferred financing fees		400,000
Dividends declared on series B preferred stock	9,986	9,986
Right of use assets and right of use liabilities recognized		879,635
Initial recognition of debt discount		845,000
Deemed distribution to CEO		$ 155,694

Consolidated Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Current Assets:
Cash	$ 90,183	$ 1,915
Total Current Assets	90,183	1,915
Property and equipment, net	76,936	79,273
Rights-of-use assets	682,702	722,088
Total Assets	849,821	803,276
Current Liabilities:
Accounts payable	217,098	217,098
Accrued expenses	541,250	417,960
Accrued interest expenses on convertible notes payable	156,880	94,727
Dividend payable	64,352	54,366
Due to related party	69,903	81,277
Convertible notes payable, net of unamortized discount $96,166 (2020 - $184,388)	1,222,834	1,086,612
Derivative liability - notes and warrants	1,588,272	1,717,337
Right of use liabilities - operating leases, current	130,644	115,547
Total Current Liabilities	3,991,233	3,784,924
Long-term Notes payable	150,000
Right of use liabilities - operating leases, long term	612,362	657,457
Total Liabilities	4,753,595	4,442,381
Stockholders' Deficiency:
Additional paid-in capital	7,378,923	7,388,909
Accumulated deficit	(11,285,233)	(11,030,550)
Total Stockholders' deficiency	(3,903,774)	(3,639,105)
Total Liabilities and Stockholders' Deficiency	849,821	803,276
Series A Preferred Stock [Member]
Stockholders' Deficiency:
Preferred Stock, value	1	1
Series B Preferred Stock [Member]
Stockholders' Deficiency:
Preferred Stock, value	125	125
Class B Common Stock [Member]
Stockholders' Deficiency:
Common Stock, value
Class A Common Stock [Member]
Stockholders' Deficiency:
Common Stock, value	$ 2,410	$ 2,410